nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—TUBB2B—Docetaxel—pancreatic cancer	0.08	0.105	CbGbCtD
Vinorelbine—TUBB6—Docetaxel—pancreatic cancer	0.08	0.105	CbGbCtD
Vinorelbine—TUBB8—Docetaxel—pancreatic cancer	0.08	0.105	CbGbCtD
Vinorelbine—TUBB4A—Docetaxel—pancreatic cancer	0.08	0.105	CbGbCtD
Vinorelbine—TUBB3—Docetaxel—pancreatic cancer	0.08	0.105	CbGbCtD
Vinorelbine—TUBB2A—Docetaxel—pancreatic cancer	0.08	0.105	CbGbCtD
Vinorelbine—TUBB—Docetaxel—pancreatic cancer	0.067	0.0878	CbGbCtD
Vinorelbine—TUBB4B—Docetaxel—pancreatic cancer	0.067	0.0878	CbGbCtD
Vinorelbine—TUBB1—Docetaxel—pancreatic cancer	0.067	0.0878	CbGbCtD
Vinorelbine—ABCB1—Tamoxifen—pancreatic cancer	0.00847	0.0111	CbGbCtD
Vinorelbine—CYP2D6—Tamoxifen—pancreatic cancer	0.00798	0.0105	CbGbCtD
Vinorelbine—ABCB1—Gemcitabine—pancreatic cancer	0.0073	0.00956	CbGbCtD
Vinorelbine—ABCB1—Erlotinib—pancreatic cancer	0.0072	0.00944	CbGbCtD
Vinorelbine—CYP2D6—Erlotinib—pancreatic cancer	0.00678	0.00889	CbGbCtD
Vinorelbine—ABCB1—Irinotecan—pancreatic cancer	0.0065	0.00852	CbGbCtD
Vinorelbine—CYP3A4—Tamoxifen—pancreatic cancer	0.00507	0.00665	CbGbCtD
Vinorelbine—ABCB1—Docetaxel—pancreatic cancer	0.00477	0.00625	CbGbCtD
Vinorelbine—ABCB1—Sunitinib—pancreatic cancer	0.00474	0.00622	CbGbCtD
Vinorelbine—CYP3A4—Erlotinib—pancreatic cancer	0.00431	0.00566	CbGbCtD
Vinorelbine—CYP3A4—Irinotecan—pancreatic cancer	0.0039	0.00511	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—pancreatic cancer	0.00355	0.00466	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—pancreatic cancer	0.00335	0.00439	CbGbCtD
Vinorelbine—CYP3A4—Docetaxel—pancreatic cancer	0.00286	0.00374	CbGbCtD
Vinorelbine—CYP3A4—Sunitinib—pancreatic cancer	0.00284	0.00373	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—pancreatic cancer	0.00213	0.00279	CbGbCtD
Vinorelbine—TUBB6—Zalcitabine—Gemcitabine—pancreatic cancer	0.00131	0.413	CbGdCrCtD
Vinorelbine—TUBB3—digestive system—pancreatic cancer	0.000988	0.0763	CbGeAlD
Vinorelbine—TUBB2B—islet of Langerhans—pancreatic cancer	0.000968	0.0747	CbGeAlD
Vinorelbine—TUBB—islet of Langerhans—pancreatic cancer	0.000916	0.0707	CbGeAlD
Vinorelbine—TUBB2A—islet of Langerhans—pancreatic cancer	0.000911	0.0703	CbGeAlD
Vinorelbine—TUBB6—islet of Langerhans—pancreatic cancer	0.000898	0.0694	CbGeAlD
Vinorelbine—TUBB4B—islet of Langerhans—pancreatic cancer	0.000781	0.0603	CbGeAlD
Vinorelbine—TUBB4A—pancreas—pancreatic cancer	0.000704	0.0543	CbGeAlD
Vinorelbine—TUBB2B—pancreas—pancreatic cancer	0.00068	0.0525	CbGeAlD
Vinorelbine—TUBB—Azacitidine—Gemcitabine—pancreatic cancer	0.000667	0.21	CbGdCrCtD
Vinorelbine—TUBB—pancreas—pancreatic cancer	0.000644	0.0497	CbGeAlD
Vinorelbine—TUBB2A—pancreas—pancreatic cancer	0.00064	0.0494	CbGeAlD
Vinorelbine—TUBB6—pancreas—pancreatic cancer	0.000632	0.0488	CbGeAlD
Vinorelbine—TUBB4A—digestive system—pancreatic cancer	0.000601	0.0464	CbGeAlD
Vinorelbine—TUBB2B—digestive system—pancreatic cancer	0.000581	0.0449	CbGeAlD
Vinorelbine—TUBB4B—pancreas—pancreatic cancer	0.000549	0.0424	CbGeAlD
Vinorelbine—TUBB2A—digestive system—pancreatic cancer	0.000547	0.0422	CbGeAlD
Vinorelbine—TUBB6—digestive system—pancreatic cancer	0.000539	0.0417	CbGeAlD
Vinorelbine—TUBB4B—digestive system—pancreatic cancer	0.000469	0.0362	CbGeAlD
Vinorelbine—TUBB6—Clomifene—Tamoxifen—pancreatic cancer	0.000467	0.147	CbGdCrCtD
Vinorelbine—TUBB6—Toremifene—Tamoxifen—pancreatic cancer	0.000456	0.144	CbGdCrCtD
Vinorelbine—TUBB6—Azacitidine—Gemcitabine—pancreatic cancer	0.000276	0.0868	CbGdCrCtD
Vinorelbine—ABCB1—islet of Langerhans—pancreatic cancer	0.000227	0.0175	CbGeAlD
Vinorelbine—CYP3A4—digestive system—pancreatic cancer	0.000193	0.0149	CbGeAlD
Vinorelbine—CYP2D6—digestive system—pancreatic cancer	0.00019	0.0146	CbGeAlD
Vinorelbine—ABCB1—pancreas—pancreatic cancer	0.00016	0.0123	CbGeAlD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—FOXM1—pancreatic cancer	0.000156	0.0106	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000155	0.0105	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000155	0.0105	CbGpPWpGaD
Vinorelbine—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1A—pancreatic cancer	0.000155	0.0105	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00015	0.0101	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000145	0.0098	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000142	0.00958	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—SYCP1—pancreatic cancer	0.000139	0.00938	CbGpPWpGaD
Vinorelbine—ABCB1—digestive system—pancreatic cancer	0.000136	0.0105	CbGeAlD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000132	0.00892	CbGpPWpGaD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000132	0.00892	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000131	0.00884	CbGpPWpGaD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000127	0.00862	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000127	0.0086	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—SYCP1—pancreatic cancer	0.000127	0.00858	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000126	0.00854	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000126	0.00854	CbGpPWpGaD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000123	0.00835	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000122	0.00825	CbGpPWpGaD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000121	0.00816	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000118	0.00799	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000116	0.00787	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000115	0.00781	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000109	0.000527	CcSEcCtD
Vinorelbine—Asthenia—Sunitinib—pancreatic cancer	0.000108	0.000526	CcSEcCtD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	0.000108	0.00733	CbGpPWpGaD
Vinorelbine—Decreased appetite—Irinotecan—pancreatic cancer	0.000108	0.000525	CcSEcCtD
Vinorelbine—Arrhythmia—Docetaxel—pancreatic cancer	0.000108	0.000525	CcSEcCtD
Vinorelbine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000108	0.000524	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000107	0.000521	CcSEcCtD
Vinorelbine—Fatigue—Irinotecan—pancreatic cancer	0.000107	0.00052	CcSEcCtD
Vinorelbine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000107	0.000519	CcSEcCtD
Vinorelbine—Alopecia—Docetaxel—pancreatic cancer	0.000107	0.000519	CcSEcCtD
Vinorelbine—Pruritus—Sunitinib—pancreatic cancer	0.000107	0.000518	CcSEcCtD
Vinorelbine—Constipation—Irinotecan—pancreatic cancer	0.000106	0.000516	CcSEcCtD
Vinorelbine—Pain—Irinotecan—pancreatic cancer	0.000106	0.000516	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000106	0.000516	CcSEcCtD
Vinorelbine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000106	0.000515	CcSEcCtD
Vinorelbine—Malnutrition—Docetaxel—pancreatic cancer	0.000105	0.000511	CcSEcCtD
Vinorelbine—Erythema—Docetaxel—pancreatic cancer	0.000105	0.000511	CcSEcCtD
Vinorelbine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000105	0.000511	CcSEcCtD
Vinorelbine—Nausea—Tamoxifen—pancreatic cancer	0.000105	0.000508	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000105	0.000508	CcSEcCtD
Vinorelbine—Fatigue—Gemcitabine—pancreatic cancer	0.000105	0.000507	CcSEcCtD
Vinorelbine—Muscular weakness—Epirubicin—pancreatic cancer	0.000104	0.000505	CcSEcCtD
Vinorelbine—Constipation—Gemcitabine—pancreatic cancer	0.000104	0.000503	CcSEcCtD
Vinorelbine—Pain—Gemcitabine—pancreatic cancer	0.000104	0.000503	CcSEcCtD
Vinorelbine—Nausea—Erlotinib—pancreatic cancer	0.000104	0.000503	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000104	0.00701	CbGpPWpGaD
Vinorelbine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000104	0.000503	CcSEcCtD
Vinorelbine—Diarrhoea—Sunitinib—pancreatic cancer	0.000103	0.000501	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000103	0.000499	CcSEcCtD
Vinorelbine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000103	0.000497	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000102	0.000496	CcSEcCtD
Vinorelbine—Dysphagia—Epirubicin—pancreatic cancer	0.000102	0.000495	CcSEcCtD
Vinorelbine—Back pain—Docetaxel—pancreatic cancer	0.000102	0.000495	CcSEcCtD
Vinorelbine—Pain—Fluorouracil—pancreatic cancer	0.000102	0.000494	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000102	0.000494	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—FUT8—pancreatic cancer	0.0001	0.00678	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—FUT8—pancreatic cancer	0.0001	0.00678	CbGpPWpGaD
Vinorelbine—Pancreatitis—Epirubicin—pancreatic cancer	0.0001	0.000485	CcSEcCtD
Vinorelbine—Dizziness—Sunitinib—pancreatic cancer	0.0001	0.000485	CcSEcCtD
Vinorelbine—Feeling abnormal—Gemcitabine—pancreatic cancer	9.99e-05	0.000485	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—pancreatic cancer	9.94e-05	0.000482	CcSEcCtD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—CDH1—pancreatic cancer	9.91e-05	0.0067	CbGpPWpGaD
Vinorelbine—Abdominal pain—Irinotecan—pancreatic cancer	9.84e-05	0.000477	CcSEcCtD
Vinorelbine—Body temperature increased—Irinotecan—pancreatic cancer	9.84e-05	0.000477	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	9.84e-05	0.000477	CcSEcCtD
Vinorelbine—Feeling abnormal—Fluorouracil—pancreatic cancer	9.83e-05	0.000476	CcSEcCtD
Vinorelbine—Anaemia—Docetaxel—pancreatic cancer	9.75e-05	0.000473	CcSEcCtD
Vinorelbine—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	9.74e-05	0.00659	CbGpPWpGaD
Vinorelbine—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	9.74e-05	0.00659	CbGpPWpGaD
Vinorelbine—Pancytopenia—Epirubicin—pancreatic cancer	9.69e-05	0.00047	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—FUT8—pancreatic cancer	9.69e-05	0.00655	CbGpPWpGaD
Vinorelbine—TUBB—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	9.65e-05	0.00653	CbGpPWpGaD
Vinorelbine—Muscular weakness—Doxorubicin—pancreatic cancer	9.64e-05	0.000467	CcSEcCtD
Vinorelbine—Vomiting—Sunitinib—pancreatic cancer	9.61e-05	0.000466	CcSEcCtD
Vinorelbine—Body temperature increased—Gemcitabine—pancreatic cancer	9.59e-05	0.000465	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—pancreatic cancer	9.55e-05	0.000463	CcSEcCtD
Vinorelbine—Rash—Sunitinib—pancreatic cancer	9.53e-05	0.000462	CcSEcCtD
Vinorelbine—Dermatitis—Sunitinib—pancreatic cancer	9.52e-05	0.000462	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	9.48e-05	0.00641	CbGpPWpGaD
Vinorelbine—Urticaria—Fluorouracil—pancreatic cancer	9.47e-05	0.000459	CcSEcCtD
Vinorelbine—Headache—Sunitinib—pancreatic cancer	9.47e-05	0.000459	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—pancreatic cancer	9.45e-05	0.000458	CcSEcCtD
Vinorelbine—Leukopenia—Docetaxel—pancreatic cancer	9.44e-05	0.000458	CcSEcCtD
Vinorelbine—Body temperature increased—Fluorouracil—pancreatic cancer	9.43e-05	0.000457	CcSEcCtD
Vinorelbine—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	9.4e-05	0.00636	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—FUT8—pancreatic cancer	9.38e-05	0.00634	CbGpPWpGaD
Vinorelbine—Palpitations—Docetaxel—pancreatic cancer	9.32e-05	0.000452	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—pancreatic cancer	9.26e-05	0.000449	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—pancreatic cancer	9.24e-05	0.000448	CcSEcCtD
Vinorelbine—Cough—Docetaxel—pancreatic cancer	9.2e-05	0.000446	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—pancreatic cancer	9.2e-05	0.000446	CcSEcCtD
Vinorelbine—Hypersensitivity—Irinotecan—pancreatic cancer	9.17e-05	0.000445	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—FUT8—pancreatic cancer	9.17e-05	0.0062	CbGpPWpGaD
Vinorelbine—Pneumonia—Epirubicin—pancreatic cancer	9.16e-05	0.000444	CcSEcCtD
Vinorelbine—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	9.11e-05	0.00616	CbGpPWpGaD
Vinorelbine—Hypertension—Docetaxel—pancreatic cancer	9.1e-05	0.000441	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—pancreatic cancer	9.1e-05	0.000441	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—pancreatic cancer	9.1e-05	0.000441	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	9.07e-05	0.00613	CbGpPWpGaD
Vinorelbine—Chest pain—Docetaxel—pancreatic cancer	8.98e-05	0.000435	CcSEcCtD
Vinorelbine—Arthralgia—Docetaxel—pancreatic cancer	8.98e-05	0.000435	CcSEcCtD
Vinorelbine—Myalgia—Docetaxel—pancreatic cancer	8.98e-05	0.000435	CcSEcCtD
Vinorelbine—Nausea—Sunitinib—pancreatic cancer	8.98e-05	0.000435	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—pancreatic cancer	8.97e-05	0.000435	CcSEcCtD
Vinorelbine—Asthenia—Irinotecan—pancreatic cancer	8.93e-05	0.000433	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—pancreatic cancer	8.92e-05	0.000433	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	8.92e-05	0.000432	CcSEcCtD
Vinorelbine—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	8.91e-05	0.00602	CbGpPWpGaD
Vinorelbine—Stomatitis—Epirubicin—pancreatic cancer	8.87e-05	0.00043	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—pancreatic cancer	8.83e-05	0.000428	CcSEcCtD
Vinorelbine—Hypersensitivity—Fluorouracil—pancreatic cancer	8.79e-05	0.000426	CcSEcCtD
Vinorelbine—Asthenia—Gemcitabine—pancreatic cancer	8.7e-05	0.000422	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Epirubicin—pancreatic cancer	8.61e-05	0.000417	CcSEcCtD
Vinorelbine—Anaphylactic shock—Docetaxel—pancreatic cancer	8.61e-05	0.000417	CcSEcCtD
Vinorelbine—Pruritus—Gemcitabine—pancreatic cancer	8.58e-05	0.000416	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—RBBP8—pancreatic cancer	8.57e-05	0.00579	CbGpPWpGaD
Vinorelbine—Infection—Docetaxel—pancreatic cancer	8.55e-05	0.000415	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—pancreatic cancer	8.55e-05	0.000414	CcSEcCtD
Vinorelbine—Diarrhoea—Irinotecan—pancreatic cancer	8.52e-05	0.000413	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—pancreatic cancer	8.49e-05	0.000412	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—pancreatic cancer	8.47e-05	0.000411	CcSEcCtD
Vinorelbine—Nervous system disorder—Docetaxel—pancreatic cancer	8.44e-05	0.000409	CcSEcCtD
Vinorelbine—Pruritus—Fluorouracil—pancreatic cancer	8.44e-05	0.000409	CcSEcCtD
Vinorelbine—Thrombocytopenia—Docetaxel—pancreatic cancer	8.43e-05	0.000409	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—pancreatic cancer	8.42e-05	0.000408	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—pancreatic cancer	8.42e-05	0.000408	CcSEcCtD
Vinorelbine—Tachycardia—Docetaxel—pancreatic cancer	8.4e-05	0.000407	CcSEcCtD
Vinorelbine—Skin disorder—Docetaxel—pancreatic cancer	8.36e-05	0.000405	CcSEcCtD
Vinorelbine—Diarrhoea—Gemcitabine—pancreatic cancer	8.3e-05	0.000402	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.26e-05	0.0004	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—FUT8—pancreatic cancer	8.24e-05	0.00557	CbGpPWpGaD
Vinorelbine—Dizziness—Irinotecan—pancreatic cancer	8.23e-05	0.000399	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—pancreatic cancer	8.21e-05	0.000398	CcSEcCtD
Vinorelbine—Anorexia—Docetaxel—pancreatic cancer	8.2e-05	0.000398	CcSEcCtD
Vinorelbine—Diarrhoea—Fluorouracil—pancreatic cancer	8.16e-05	0.000396	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—pancreatic cancer	8.13e-05	0.000394	CcSEcCtD
Vinorelbine—Hypotension—Docetaxel—pancreatic cancer	8.04e-05	0.00039	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—pancreatic cancer	8.03e-05	0.000389	CcSEcCtD
Vinorelbine—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	8e-05	0.00541	CbGpPWpGaD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—pancreatic cancer	7.98e-05	0.00539	CbGpPWpGaD
Vinorelbine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.97e-05	0.000386	CcSEcCtD
Vinorelbine—Vomiting—Irinotecan—pancreatic cancer	7.92e-05	0.000384	CcSEcCtD
Vinorelbine—Dizziness—Fluorouracil—pancreatic cancer	7.89e-05	0.000382	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—pancreatic cancer	7.86e-05	0.000381	CcSEcCtD
Vinorelbine—Rash—Irinotecan—pancreatic cancer	7.85e-05	0.000381	CcSEcCtD
Vinorelbine—Dermatitis—Irinotecan—pancreatic cancer	7.84e-05	0.00038	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.84e-05	0.00038	CcSEcCtD
Vinorelbine—Headache—Irinotecan—pancreatic cancer	7.8e-05	0.000378	CcSEcCtD
Vinorelbine—Paraesthesia—Docetaxel—pancreatic cancer	7.73e-05	0.000375	CcSEcCtD
Vinorelbine—Vomiting—Gemcitabine—pancreatic cancer	7.71e-05	0.000374	CcSEcCtD
Vinorelbine—Dyspnoea—Docetaxel—pancreatic cancer	7.67e-05	0.000372	CcSEcCtD
Vinorelbine—Rash—Gemcitabine—pancreatic cancer	7.65e-05	0.000371	CcSEcCtD
Vinorelbine—Dermatitis—Gemcitabine—pancreatic cancer	7.64e-05	0.00037	CcSEcCtD
Vinorelbine—Headache—Gemcitabine—pancreatic cancer	7.6e-05	0.000368	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—pancreatic cancer	7.58e-05	0.000368	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—pancreatic cancer	7.58e-05	0.000368	CcSEcCtD
Vinorelbine—Vomiting—Fluorouracil—pancreatic cancer	7.58e-05	0.000368	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—FUT8—pancreatic cancer	7.53e-05	0.00509	CbGpPWpGaD
Vinorelbine—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.52e-05	0.000365	CcSEcCtD
Vinorelbine—Rash—Fluorouracil—pancreatic cancer	7.52e-05	0.000364	CcSEcCtD
Vinorelbine—Dermatitis—Fluorouracil—pancreatic cancer	7.51e-05	0.000364	CcSEcCtD
Vinorelbine—Decreased appetite—Docetaxel—pancreatic cancer	7.48e-05	0.000363	CcSEcCtD
Vinorelbine—Headache—Fluorouracil—pancreatic cancer	7.47e-05	0.000362	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	7.45e-05	0.00504	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.43e-05	0.00036	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.43e-05	0.00036	CcSEcCtD
Vinorelbine—Fatigue—Docetaxel—pancreatic cancer	7.42e-05	0.00036	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—pancreatic cancer	7.41e-05	0.000359	CcSEcCtD
Vinorelbine—Nausea—Irinotecan—pancreatic cancer	7.4e-05	0.000359	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—pancreatic cancer	7.38e-05	0.000358	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—pancreatic cancer	7.36e-05	0.000357	CcSEcCtD
Vinorelbine—Constipation—Docetaxel—pancreatic cancer	7.36e-05	0.000357	CcSEcCtD
Vinorelbine—Pain—Docetaxel—pancreatic cancer	7.36e-05	0.000357	CcSEcCtD
Vinorelbine—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—pancreatic cancer	7.31e-05	0.00495	CbGpPWpGaD
Vinorelbine—Arrhythmia—Epirubicin—pancreatic cancer	7.3e-05	0.000354	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—pancreatic cancer	7.22e-05	0.00035	CcSEcCtD
Vinorelbine—Nausea—Gemcitabine—pancreatic cancer	7.2e-05	0.000349	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—pancreatic cancer	7.11e-05	0.000345	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—pancreatic cancer	7.11e-05	0.000345	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—RBBP8—pancreatic cancer	7.1e-05	0.0048	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Docetaxel—pancreatic cancer	7.09e-05	0.000344	CcSEcCtD
Vinorelbine—Nausea—Fluorouracil—pancreatic cancer	7.08e-05	0.000343	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.04e-05	0.000341	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—pancreatic cancer	7.02e-05	0.00034	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—pancreatic cancer	7.02e-05	0.00034	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—pancreatic cancer	6.88e-05	0.000334	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—pancreatic cancer	6.86e-05	0.000333	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—pancreatic cancer	6.83e-05	0.000331	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.81e-05	0.00033	CcSEcCtD
Vinorelbine—Abdominal pain—Docetaxel—pancreatic cancer	6.8e-05	0.00033	CcSEcCtD
Vinorelbine—Body temperature increased—Docetaxel—pancreatic cancer	6.8e-05	0.00033	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—pancreatic cancer	6.75e-05	0.000327	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—pancreatic cancer	6.68e-05	0.000324	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—PPP2R5B—pancreatic cancer	6.66e-05	0.00451	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	6.64e-05	0.00449	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	6.64e-05	0.00449	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Epirubicin—pancreatic cancer	6.6e-05	0.00032	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—pancreatic cancer	6.58e-05	0.000319	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—pancreatic cancer	6.58e-05	0.000319	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—pancreatic cancer	6.57e-05	0.000319	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—RBBP8—pancreatic cancer	6.49e-05	0.00439	CbGpPWpGaD
Vinorelbine—Malaise—Epirubicin—pancreatic cancer	6.41e-05	0.000311	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—pancreatic cancer	6.39e-05	0.00031	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—pancreatic cancer	6.37e-05	0.000309	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—pancreatic cancer	6.37e-05	0.000309	CcSEcCtD
Vinorelbine—Hypersensitivity—Docetaxel—pancreatic cancer	6.34e-05	0.000307	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—pancreatic cancer	6.29e-05	0.000305	CcSEcCtD
Vinorelbine—Cough—Epirubicin—pancreatic cancer	6.21e-05	0.000301	CcSEcCtD
Vinorelbine—Asthenia—Docetaxel—pancreatic cancer	6.18e-05	0.000299	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	6.17e-05	0.00418	CbGpPWpGaD
Vinorelbine—Hypertension—Epirubicin—pancreatic cancer	6.14e-05	0.000298	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—PCSK1—pancreatic cancer	6.13e-05	0.00414	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—PCSK1—pancreatic cancer	6.13e-05	0.00414	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.11e-05	0.000296	CcSEcCtD
Vinorelbine—Pruritus—Docetaxel—pancreatic cancer	6.09e-05	0.000295	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—pancreatic cancer	6.08e-05	0.000295	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—pancreatic cancer	6.06e-05	0.000294	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—pancreatic cancer	6.06e-05	0.000294	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—pancreatic cancer	6.06e-05	0.000294	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.01e-05	0.000292	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—pancreatic cancer	5.98e-05	0.00029	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—FOXM1—pancreatic cancer	5.94e-05	0.00402	CbGpPWpGaD
Vinorelbine—Malaise—Doxorubicin—pancreatic cancer	5.94e-05	0.000288	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—PCSK1—pancreatic cancer	5.92e-05	0.004	CbGpPWpGaD
Vinorelbine—Vertigo—Doxorubicin—pancreatic cancer	5.91e-05	0.000287	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—pancreatic cancer	5.89e-05	0.000286	CcSEcCtD
Vinorelbine—Diarrhoea—Docetaxel—pancreatic cancer	5.89e-05	0.000285	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—pancreatic cancer	5.82e-05	0.000282	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—pancreatic cancer	5.81e-05	0.000281	CcSEcCtD
Vinorelbine—Infection—Epirubicin—pancreatic cancer	5.77e-05	0.00028	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—pancreatic cancer	5.74e-05	0.000278	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	5.74e-05	0.00388	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—PCSK1—pancreatic cancer	5.73e-05	0.00388	CbGpPWpGaD
Vinorelbine—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	5.7e-05	0.00386	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Epirubicin—pancreatic cancer	5.69e-05	0.000276	CcSEcCtD
Vinorelbine—Dizziness—Docetaxel—pancreatic cancer	5.69e-05	0.000276	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—pancreatic cancer	5.68e-05	0.000276	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—pancreatic cancer	5.68e-05	0.000275	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—pancreatic cancer	5.67e-05	0.000275	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	5.65e-05	0.00382	CbGpPWpGaD
Vinorelbine—Skin disorder—Epirubicin—pancreatic cancer	5.64e-05	0.000273	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—pancreatic cancer	5.6e-05	0.000272	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—pancreatic cancer	5.6e-05	0.000272	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—pancreatic cancer	5.6e-05	0.000272	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—PCSK1—pancreatic cancer	5.6e-05	0.00379	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—PPP2R5B—pancreatic cancer	5.6e-05	0.00379	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—PPP2R5B—pancreatic cancer	5.6e-05	0.00379	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.56e-05	0.00027	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—pancreatic cancer	5.54e-05	0.000268	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—pancreatic cancer	5.53e-05	0.000268	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—PPP2R5B—pancreatic cancer	5.52e-05	0.00373	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	5.5e-05	0.00372	CbGpPWpGaD
Vinorelbine—Vomiting—Docetaxel—pancreatic cancer	5.47e-05	0.000265	CcSEcCtD
Vinorelbine—Rash—Docetaxel—pancreatic cancer	5.43e-05	0.000263	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—pancreatic cancer	5.42e-05	0.000263	CcSEcCtD
Vinorelbine—Dermatitis—Docetaxel—pancreatic cancer	5.42e-05	0.000263	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—PPP2R5B—pancreatic cancer	5.41e-05	0.00366	CbGpPWpGaD
Vinorelbine—Headache—Docetaxel—pancreatic cancer	5.39e-05	0.000261	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.37e-05	0.00026	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—pancreatic cancer	5.34e-05	0.000259	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.29e-05	0.000256	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—pancreatic cancer	5.27e-05	0.000255	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.26e-05	0.000255	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—pancreatic cancer	5.24e-05	0.000254	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—PPP2R5B—pancreatic cancer	5.24e-05	0.00354	CbGpPWpGaD
Vinorelbine—Skin disorder—Doxorubicin—pancreatic cancer	5.22e-05	0.000253	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—pancreatic cancer	5.21e-05	0.000253	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—pancreatic cancer	5.18e-05	0.000251	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—PPP2R5B—pancreatic cancer	5.12e-05	0.00347	CbGpPWpGaD
Vinorelbine—Anorexia—Doxorubicin—pancreatic cancer	5.12e-05	0.000248	CcSEcCtD
Vinorelbine—Nausea—Docetaxel—pancreatic cancer	5.11e-05	0.000248	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—PPP2R5B—pancreatic cancer	5.05e-05	0.00341	CbGpPWpGaD
Vinorelbine—Decreased appetite—Epirubicin—pancreatic cancer	5.05e-05	0.000245	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	5.03e-05	0.0034	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—PCSK1—pancreatic cancer	5.03e-05	0.0034	CbGpPWpGaD
Vinorelbine—Hypotension—Doxorubicin—pancreatic cancer	5.02e-05	0.000243	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.01e-05	0.000243	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—pancreatic cancer	5.01e-05	0.000243	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—pancreatic cancer	4.96e-05	0.000241	CcSEcCtD
Vinorelbine—Pain—Epirubicin—pancreatic cancer	4.96e-05	0.000241	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—FOXM1—pancreatic cancer	4.92e-05	0.00333	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.89e-05	0.000237	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—pancreatic cancer	4.82e-05	0.000234	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—pancreatic cancer	4.79e-05	0.000232	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—pancreatic cancer	4.78e-05	0.000232	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.77e-05	0.00323	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.77e-05	0.00323	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.75e-05	0.00023	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—pancreatic cancer	4.67e-05	0.000226	CcSEcCtD
Vinorelbine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4.64e-05	0.00314	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.64e-05	0.000225	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—pancreatic cancer	4.63e-05	0.000225	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—pancreatic cancer	4.61e-05	0.000224	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.61e-05	0.00312	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—PPP2R5B—pancreatic cancer	4.6e-05	0.00311	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—PCSK1—pancreatic cancer	4.6e-05	0.00311	CbGpPWpGaD
Vinorelbine—Pain—Doxorubicin—pancreatic cancer	4.59e-05	0.000223	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—pancreatic cancer	4.59e-05	0.000223	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—pancreatic cancer	4.59e-05	0.000222	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—pancreatic cancer	4.59e-05	0.000222	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—FOXM1—pancreatic cancer	4.5e-05	0.00304	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.46e-05	0.00302	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Doxorubicin—pancreatic cancer	4.43e-05	0.000215	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.39e-05	0.000213	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.36e-05	0.00295	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Epirubicin—pancreatic cancer	4.28e-05	0.000207	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—pancreatic cancer	4.27e-05	0.000207	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—pancreatic cancer	4.25e-05	0.000206	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—pancreatic cancer	4.25e-05	0.000206	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—PPP2R5B—pancreatic cancer	4.21e-05	0.00285	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	4.17e-05	0.00282	CbGpPWpGaD
Vinorelbine—Asthenia—Epirubicin—pancreatic cancer	4.17e-05	0.000202	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—pancreatic cancer	4.11e-05	0.000199	CcSEcCtD
Vinorelbine—Diarrhoea—Epirubicin—pancreatic cancer	3.97e-05	0.000193	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.96e-05	0.000192	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	3.94e-05	0.00266	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	3.92e-05	0.00265	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.92e-05	0.00265	CbGpPWpGaD
Vinorelbine—Asthenia—Doxorubicin—pancreatic cancer	3.85e-05	0.000187	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—pancreatic cancer	3.84e-05	0.000186	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—pancreatic cancer	3.8e-05	0.000184	CcSEcCtD
Vinorelbine—Vomiting—Epirubicin—pancreatic cancer	3.69e-05	0.000179	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—pancreatic cancer	3.68e-05	0.000178	CcSEcCtD
Vinorelbine—Rash—Epirubicin—pancreatic cancer	3.66e-05	0.000177	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—pancreatic cancer	3.66e-05	0.000177	CcSEcCtD
Vinorelbine—Headache—Epirubicin—pancreatic cancer	3.64e-05	0.000176	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.58e-05	0.00242	CbGpPWpGaD
Vinorelbine—Dizziness—Doxorubicin—pancreatic cancer	3.55e-05	0.000172	CcSEcCtD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	3.53e-05	0.00239	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TYMS—pancreatic cancer	3.46e-05	0.00234	CbGpPWpGaD
Vinorelbine—Nausea—Epirubicin—pancreatic cancer	3.45e-05	0.000167	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—pancreatic cancer	3.42e-05	0.000166	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—pancreatic cancer	3.39e-05	0.000164	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—pancreatic cancer	3.38e-05	0.000164	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—pancreatic cancer	3.37e-05	0.000163	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	3.36e-05	0.00227	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—BRCA2—pancreatic cancer	3.25e-05	0.0022	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—GCG—pancreatic cancer	3.22e-05	0.00218	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—GCG—pancreatic cancer	3.22e-05	0.00218	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	3.21e-05	0.00217	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—pancreatic cancer	3.19e-05	0.000155	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—GCG—pancreatic cancer	3.11e-05	0.0021	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TYMS—pancreatic cancer	3.09e-05	0.00209	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—GCG—pancreatic cancer	3.01e-05	0.00204	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—GCG—pancreatic cancer	2.94e-05	0.00199	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	2.94e-05	0.00199	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	2.88e-05	0.00195	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TYMS—pancreatic cancer	2.87e-05	0.00194	CbGpPWpGaD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	2.86e-05	0.00193	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TERT—pancreatic cancer	2.7e-05	0.00182	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—BRCA2—pancreatic cancer	2.7e-05	0.00182	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—GCG—pancreatic cancer	2.64e-05	0.00179	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	2.63e-05	0.00178	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TYMS—pancreatic cancer	2.62e-05	0.00177	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	2.6e-05	0.00176	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TYMS—pancreatic cancer	2.56e-05	0.00173	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—BRCA2—pancreatic cancer	2.47e-05	0.00167	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—GCG—pancreatic cancer	2.42e-05	0.00163	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RB1—pancreatic cancer	2.35e-05	0.00159	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TYMS—pancreatic cancer	2.35e-05	0.00159	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	2.27e-05	0.00154	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	2.23e-05	0.00151	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TERT—pancreatic cancer	2.23e-05	0.00151	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RB1—pancreatic cancer	2.1e-05	0.00142	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	2.06e-05	0.0014	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TERT—pancreatic cancer	2.04e-05	0.00138	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	1.97e-05	0.00134	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RB1—pancreatic cancer	1.94e-05	0.00131	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	1.91e-05	0.00129	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—pancreatic cancer	1.84e-05	0.00125	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	1.8e-05	0.00122	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RB1—pancreatic cancer	1.78e-05	0.0012	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.74e-05	0.00118	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RB1—pancreatic cancer	1.74e-05	0.00118	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	1.73e-05	0.00117	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	1.73e-05	0.00117	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.71e-05	0.00116	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—MMP2—pancreatic cancer	1.69e-05	0.00114	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—MMP2—pancreatic cancer	1.69e-05	0.00114	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	1.69e-05	0.00114	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	1.68e-05	0.00113	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	1.65e-05	0.00111	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—MMP2—pancreatic cancer	1.63e-05	0.00111	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RB1—pancreatic cancer	1.59e-05	0.00108	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—MMP2—pancreatic cancer	1.58e-05	0.00107	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.56e-05	0.00106	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—pancreatic cancer	1.56e-05	0.00105	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—MMP2—pancreatic cancer	1.55e-05	0.00105	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—pancreatic cancer	1.53e-05	0.00103	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	1.46e-05	0.00099	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.44e-05	0.000977	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CXCL8—pancreatic cancer	1.41e-05	0.000951	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CXCL8—pancreatic cancer	1.41e-05	0.000951	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.4e-05	0.000945	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—pancreatic cancer	1.4e-05	0.000945	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—MMP2—pancreatic cancer	1.39e-05	0.00094	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CXCL8—pancreatic cancer	1.36e-05	0.000919	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	1.34e-05	0.000909	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.32e-05	0.000893	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CXCL8—pancreatic cancer	1.32e-05	0.00089	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CTNNB1—pancreatic cancer	1.3e-05	0.000878	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CTNNB1—pancreatic cancer	1.3e-05	0.000878	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—pancreatic cancer	1.29e-05	0.000873	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CXCL8—pancreatic cancer	1.29e-05	0.00087	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—MMP2—pancreatic cancer	1.27e-05	0.00086	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.26e-05	0.000849	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CTNNB1—pancreatic cancer	1.25e-05	0.000848	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—pancreatic cancer	1.25e-05	0.000845	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.25e-05	0.000844	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CTNNB1—pancreatic cancer	1.21e-05	0.000821	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.19e-05	0.000808	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CTNNB1—pancreatic cancer	1.19e-05	0.000803	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—pancreatic cancer	1.18e-05	0.000799	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.16e-05	0.000783	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CXCL8—pancreatic cancer	1.16e-05	0.000781	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.09e-05	0.000736	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.08e-05	0.00073	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CTNNB1—pancreatic cancer	1.07e-05	0.000721	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.06e-05	0.000716	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CXCL8—pancreatic cancer	1.06e-05	0.000715	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—pancreatic cancer	1.04e-05	0.0007	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—pancreatic cancer	1.03e-05	0.000694	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CTNNB1—pancreatic cancer	9.75e-06	0.000659	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—pancreatic cancer	9.47e-06	0.000641	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	9.17e-06	0.000621	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PRSS1—pancreatic cancer	8.94e-06	0.000605	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	8.52e-06	0.000576	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—pancreatic cancer	8.5e-06	0.000575	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	8.42e-06	0.00057	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	8.29e-06	0.000561	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	8.21e-06	0.000555	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	8e-06	0.000541	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—pancreatic cancer	7.78e-06	0.000526	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ARG2—pancreatic cancer	7.75e-06	0.000524	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	7.42e-06	0.000502	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ARG2—pancreatic cancer	7.3e-06	0.000494	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	7.23e-06	0.000489	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMP—pancreatic cancer	6.78e-06	0.000458	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	6.65e-06	0.00045	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	6.63e-06	0.000449	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	6.5e-06	0.00044	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMP—pancreatic cancer	6.38e-06	0.000432	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	6.19e-06	0.000419	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	6.14e-06	0.000416	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	5.64e-06	0.000382	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.51e-06	0.000373	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GLP1R—pancreatic cancer	5.46e-06	0.000369	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.46e-06	0.000369	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—DPYD—pancreatic cancer	5.37e-06	0.000363	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	5.15e-06	0.000348	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	5.1e-06	0.000345	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.06e-06	0.000342	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	4.8e-06	0.000325	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.78e-06	0.000323	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.61e-06	0.000312	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.17e-06	0.000282	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CD44—pancreatic cancer	3.95e-06	0.000267	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GCG—pancreatic cancer	3.79e-06	0.000256	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CD44—pancreatic cancer	3.72e-06	0.000252	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GCG—pancreatic cancer	3.57e-06	0.000241	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—STK11—pancreatic cancer	3.56e-06	0.000241	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.36e-06	0.000228	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—STK11—pancreatic cancer	3.35e-06	0.000227	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.31e-06	0.000224	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.14e-06	0.000212	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMS—pancreatic cancer	3.06e-06	0.000207	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.89e-06	0.000195	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APOE—pancreatic cancer	2.49e-06	0.000168	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CD44—pancreatic cancer	2.43e-06	0.000165	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APOE—pancreatic cancer	2.35e-06	0.000159	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GCG—pancreatic cancer	2.33e-06	0.000158	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.25e-06	0.000152	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—STK11—pancreatic cancer	2.19e-06	0.000148	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARG—pancreatic cancer	2.17e-06	0.000147	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.12e-06	0.000143	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.04e-06	0.000138	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.98e-06	0.000134	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.89e-06	0.000128	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.86e-06	0.000126	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.72e-06	0.000116	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.71e-06	0.000115	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.62e-06	0.00011	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.61e-06	0.000109	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.53e-06	0.000104	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.49e-06	0.000101	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.4e-06	9.48e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.38e-06	9.36e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.34e-06	9.04e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.22e-06	8.23e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.06e-06	7.18e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.05e-06	7.11e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.05e-06	7.1e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	9.89e-07	6.69e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—pancreatic cancer	9.17e-07	6.2e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—pancreatic cancer	8.57e-07	5.8e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—pancreatic cancer	8.08e-07	5.47e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.47e-07	4.37e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.28e-07	3.57e-05	CbGpPWpGaD
